Sanofi's Total Voting Rights and Shares Overview
Sanofi, a prominent name in the pharmaceutical industry, provides updates on the total number of voting rights and shares as part of the requirements set forth by the French Commercial Code. Their corporate structure allows them to operate effectively while maintaining compliance with regulatory standards.
Key Information Regarding Shares
Sanofi has a registered share capital of approximately €2.45 billion, emphasizing its robust financial standing. With the registered office located at 46, avenue de la Grande Armée, Paris, the company is officially documented under number 395 030 844 in the Paris Commercial and Companies Registry.
Current Share Details as of September 30, 2025
As of the latest reporting date, Sanofi has disclosed the following share statistics:
- Total number of issued shares: 1,227,469,992
- Number of real voting rights (excluding treasury shares): 1,352,290,790
- Theoretical number of voting rights (including treasury shares): 1,361,772,559
The precise understanding of these figures is critical for investors and stakeholders, as it showcases Sanofi's commitment to transparency in its voting rights structure.
Importance of Voting Rights
Voting rights play a crucial role in corporate governance. They grant shareholders the power to influence major company decisions, which can ultimately impact financial performance. With more than a billion voting rights available, Sanofi allows its shareholders to actively participate in the governance processes.
Understanding the Shareholder Framework
Sanofi's governance framework is designed to foster shareholder engagement. By ensuring clarity regarding voting rights, shareholders can make informed decisions regarding their investments. Additionally, such transparency is essential for building trust within the investor community.
Staying Updated with Sanofi
Complete information about Sanofi's shares and voting rights is made available on their corporate website under the 'Regulated Information in France' section. Regular updates from such important data enable investors to stay informed about the company's structure and its implications for shareholders.
Contacting Investor Relations
Investors looking for more detailed information can reach out to Sanofi's Investor Relations Department via email at investor.relations@sanofi.com. This department is dedicated to addressing shareholder inquiries and providing relevant updates that might concern investor interests.
Frequently Asked Questions
What is the total number of shares issued by Sanofi?
As of September 30, 2025, Sanofi has issued a total of 1,227,469,992 shares.
How many real voting rights does Sanofi have?
Sanofi has approximately 1,352,290,790 real voting rights excluding treasury shares.
What is the theoretical number of voting rights including treasury shares?
The theoretical number of voting rights, including treasury shares, is 1,361,772,559.
Where can I find Sanofi's regulated information?
Sanofi's regulated information can be found on their corporate website under the "Regulated Information in France" section.
How can I contact Sanofi's investor relations?
You can contact Sanofi's Investor Relations Department through email at investor.relations@sanofi.com.
